| Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion R Zang, JB Case, E Yutuc, X Ma, S Shen, MF Gomez Castro, Z Liu, ... Proceedings of the National Academy of Sciences 117 (50), 32105-32113, 2020 | 200 | 2020 |
| The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation Q Long, R Yan, J Hu, D Cai, B Mitra, ES Kim, A Marchetti, H Zhang, ... PLoS pathogens 13 (12), e1006784, 2017 | 117 | 2017 |
| Biogenesis and molecular characteristics of serum hepatitis B virus RNA S Shen, Z Xie, D Cai, X Yu, HU Zhang, ES Kim, B Zhou, J Hou, X Zhang, ... PLoS pathogens 16 (10), e1008945, 2020 | 38 | 2020 |
| Single-cell analysis of the impact of host-cell heterogeneity on infection with foot and mouth disease virus C Xin, Xiu Wang, Hailong Han, Lingling Wang, Mingzhen Fang, Hui Hao, Yao Li ... Journal of Virology, 2018 | 38 | 2018 |
| SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive … F Zhang, W Li, J Feng, S Ramos da Silva, E Ju, H Zhang, Y Chang, ... Journal of medical virology 93 (12), 6671-6685, 2021 | 27 | 2021 |
| Characterization of the termini of cytoplasmic hepatitis B virus deproteinated relaxed circular DNA D Cai, R Yan, JZ Xu, H Zhang, S Shen, B Mitra, A Marchetti, ES Kim, ... Journal of Virology 95 (1), 10.1128/jvi. 00922-20, 2020 | 23 | 2020 |
| Global transcriptional analysis of model of persistent FMDV infection reveals critical role of host cells in persistence H Zhang, Y Li, X Huang, C Zheng Veterinary microbiology 162 (2-4), 321-329, 2013 | 20 | 2013 |
| Construction and characterization of two SARS‐CoV‐2 minigenome replicon systems H Zhang, DK Fischer, M Shuda, PS Moore, SJ Gao, Z Ambrose, H Guo Journal of medical virology 94 (6), 2438-2452, 2022 | 12 | 2022 |
| RNA helicase DDX17 inhibits hepatitis B virus replication by blocking viral pregenomic RNA encapsidation R Mao, M Dong, Z Shen, H Zhang, Y Liu, D Cai, B Mitra, J Zhang, H Guo Journal of Virology 95 (19), 10.1128/jvi. 00444-21, 2021 | 12 | 2021 |
| Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA ES Kim, J Zhou, H Zhang, A Marchetti, M van de Klundert, D Cai, X Yu, ... PLoS Pathogens 18 (6), e1010576, 2022 | 8 | 2022 |
| Naturally occurring core protein mutations compensate for the reduced replication fitness of a lamivudine-resistant HBV isolate H Yongmei Zhang, Hu Zhang, Junjie Zhang, Jiming Zhang, Guo Antiviral Research 165, 47-54, 2019 | 7 | 2019 |
| Development and characterization of a new monoclonal antibody against SARS‐CoV‐2 NSP12 (RdRp) W Meng, S Guo, S Cao, M Shuda, LR Robinson‐McCarthy, KR McCarthy, ... Journal of medical virology 95 (1), e28246, 2023 | 4 | 2023 |
| Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription X Yu, Q Long, S Shen, Z Liu, J Chandran, J Zhang, H Ding, H Zhang, ... Antiviral Research 211, 105552, 2023 | 3 | 2023 |
| Proteomic Analysis of Nuclear HBV rcDNA Associated Proteins Identifies UV-DDB as a Host Factor Involved in cccDNA Formation AL Marchetti Indiana University-Purdue University Indianapolis, 2022 | 2 | 2022 |
| Optimization of a DNA‐launched SARS‐CoV‐2 replicon with RNA splicing inhibitor Isoginkgetin H Zhang, H Guo Journal of Medical Virology 96 (3), e29547, 2024 | | 2024 |
| Cross-species hybridization of foot-and-mouth disease virus-infected BHK-21 cells using human and mouse oligonucleotide microarrays H Zhang, Q Wang, L Han, C Zheng, CH Shen Acta virologica 61 (3), 299-307, 2017 | | 2017 |
